Table 7.
Studies examining human milk apelin.
| Author | Year | Sample Size (n) | Sample Type | Sampling | Time of the Day (h) |
Time of Collection |
Preparation | Method | Intra, Inter Assay (%CV) | LOD | R (%) | Concentration (ng/mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aydin [102] | 2010 | 20 | C, M | - | 08:00 | 1–4 mo | WM | EIA | - | - | - | GDM, C, apelin-12, 2.9 ± 0.6 C, apelin-36, 3.2 ± 0.7 M, apelin-12, 3.6 ± 1.2 M, apelin-36, 4.4 ± 1.4 CTL, C, apelin-12, 4.3 ± 1.2 C, apelin-36, 4.9 ± 2 M, apelin-12, 5.4 ± 1.8 M, apelin-36, 6.2 ± 1.9 |
Data reported as mean ± SD. C, colostrum milk; CTL, control group; CV %, coefficient variation percentage; EIA, enzyme immunoassay; GDM, gestational diabetes mellitus; LOD, limit of detection; M, mature milk; mo, month; R %, recovery of analyte percentage; WM, whole milk.